Search Results 141-150 of 11264 for lamotrigine

  1. https://www.mayoclinic.org/spanish_patient_consumer_web.xml

  2. https://www.mayoclinic.org/arabic_patient_consumer_video.xml

  3. Polyethylene glycol 3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride, and potassium chloride (oral route) - Mayo Clinic

    Polyethylene glycol 3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride, and potassium chloride combination is used to cleanse the bowels ...

  4. Quetiapine (oral route) - Side effects & dosage - Mayo Clinic

    Quetiapine is used alone or together with other medicines to treat bipolar disorder (depressive and manic episodes) and schizophrenia. Quetiapine extended- ...

  5. Addition Of Daratumumab To Combination Of Bortezomib And Dexamethasone In Participants With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Glipizide (oral route) - Mayo Clinic

    Glipizide belongs to a class of drugs called sulfonylureas. It stimulates the release of insulin from the pancreas, directing your body to store blood sugar.

  7. Clinical trials - Oncology (Medical)

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...

  8. Lidocaine and epinephrine (injection route) - Mayo Clinic

    Lidocaine and epinephrine combination injection is used to cause numbness or loss of feeling for patients having certain medical procedures (by blocking certain ...

  9. Ethosuximide (oral route) - Side effects & dosage - Mayo Clinic

    This medicine can be used with other seizure medicines. Keep using all of your seizure medicines unless your doctor tells you to stop. Dosing. The dose of this ...

  10. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to severely ...